Treosulfan-based conditioning in HSCT patients

Pediatr Hematol Oncol. 2020 Aug;37(5):353-354. doi: 10.1080/08880018.2020.1767440. Epub 2020 May 29.

Authors

Paul Veys^{1

2}, Delphine Veys³

Affiliations

¹ Blood and Marrow Transplantation, Great Ormond Street (GOS) Hospital for Children NHS Foundation Trust, London, United Kingdom.
² University College London GOS Institute of Child Health and National Institute for Health Research GOS Hospital Biomedical Research Centre, London, United Kingdom.
³ St. John's College Cambridge, Cambridge, United Kingdom.

PMID: 32469622
DOI: 10.1080/08880018.2020.1767440

No abstract available

Publication types

Comment

MeSH terms

Busulfan* / analogs & derivatives
Hematopoietic Stem Cell Transplantation*
Humans
Transplantation Conditioning

Substances

treosulfan
Busulfan